Drug Profile
2-Hydroxymyristic acid
Alternative Names: 2-HM; 2-Hydroxytetradecanoic acidLatest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator BTG
- Class Antivirals
- Mechanism of Action Myristoyl transferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 29 Jul 1999 2-Hydroxymyristic acid is available for licensing (http://www.btg.co.uk/technologies/anti_infectives.asp)
- 29 Jul 1999 New profile